Implementation research for promoting access and rational use of antibiotics for children: lessons learnt from Tanzania.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
medline:
24
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
epublish
Résumé
Implementation research (IR) has proved to be a potential catalyst in facilitating the uptake of evidence-based innovations into routine practices and thereby maximizing public health outcomes. IR not only focuses on the effectiveness of the innovations but also identifies and addresses the barriers and facilitators to maximize their uptake into routine practices. This article describes the processes undertaken to implement a research project aimed at promoting access and rational use of antibiotics for children (PARAC). It also provides an overview of the lessons learnt during its implementation in Tanzanian hospital and community settings.
Identifiants
pubmed: 37090916
doi: 10.1093/jacamr/dlad045
pii: dlad045
pmc: PMC10116604
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
dlad045Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Déclaration de conflit d'intérêts
During the workshop discussions, especially when the stakeholders were formulating actionable recommendations, there were always facilitator (in favour) and barrier (against) sides. However, conflict of interest among the stakeholders is something that needs to be clearly stated (noted) at the beginning of the IR process. For example, during the discussion on whether to include rapid diagnostic tests (RDTs) in the community pharmacies, there were conflicting interests between different professionals (pharmacy, medical and laboratory medicine). Some stakeholders thought that including RDTs in the community pharmacies was shifting the role of pharmacies from being dispensing outlets to health centres.
Références
Expert Opin Drug Saf. 2021 Nov;20(11):1375-1390
pubmed: 33999733
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
Antimicrob Resist Infect Control. 2019 May 28;8:87
pubmed: 31161034
Antibiotics (Basel). 2021 Apr 06;10(4):
pubmed: 33917430
BMC Public Health. 2012 Oct 24;12:904
pubmed: 23095365
J Eval Clin Pract. 2019 Jun;25(3):373-380
pubmed: 30632246
Bull World Health Organ. 2017 Feb 1;95(2):87
pubmed: 28250505